The anticoagulant effect of heparan sulfate and dermatan sulfate.
D000818:Animals; D000991:Antithrombins / Q000032:analysis; D001777:Blood Coagulation / Q000187:drug effects*; D002807:Chondroitin / Q000031:analogs & derivatives*; D002809:Chondroitin Sulfates / Q000494:pharmacology; D003871:Dermatan Sulfate / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005170:Factor X / Q000032:analysis; D006025:Glycosaminoglycans / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology; D006497:Heparan Sulfate / Q000494:pharmacology*; D006801:Humans; D006820:Hyaluronic Acid / Q000494:pharmacology; D007632:Keratan Sulfate / Q000494:pharmacology; D013917:Thrombin / Q000032:analysis / Q000037:antagonists & inhibitors; D013925:Thromboplastin / Q000032:analysis
D000991:Antithrombins; D002807:Chondroitin; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D005170:Factor X; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate; D006820:Hyaluronic Acid; D007632:Keratan Sulfate; D013917:Thrombin; D013925:Thromboplastin